Interpretations of fundus autofluorescence from studies of the bisretinoids of the retina

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 9, 2010, Pages 4351-4357

  Sparrow, Janet R ^a   Yoon, Kee Dong ^a   Wu, Yalin ^a   Yamamoto, Kazunori ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

LIPOFUSCIN; RETINAL; RETINOID DERIVATIVE; RETINOL; DRUG DERIVATIVE; RETINAL DIMER; RETINOID;

ABCA4 GENE; ARTICLE; ATROPHY; AUTOFLUORESCENCE IMAGING; CELL DAMAGE; CELL LEVEL; EPITHELIUM CELL; EYE FUNDUS; FLUORESCENCE ANALYSIS; GENE; HUMAN; LIGHT INTENSITY; PHOTOOXIDATION; PHOTORECEPTOR CELL; PHOTORECEPTOR OUTER SEGMENT; PIGMENT EPITHELIUM; PRIORITY JOURNAL; RETINA DEGENERATION; RETINA DISEASE; RETINA MACULA AGE RELATED DEGENERATION; STARGARDT DISEASE; ANIMAL; FLUORESCENCE; METABOLISM; PATHOLOGY; PHOTOCHEMICAL SMOG; PROGNOSIS; SPECTROFLUOROMETRY;

ANIMALS; FLUORESCENCE; FUNDUS OCULI; HUMANS; LIPOFUSCIN; OXIDANTS, PHOTOCHEMICAL; PHOTORECEPTOR CELLS, VERTEBRATE; PROGNOSIS; RETINAL DISEASES; RETINAL PIGMENT EPITHELIUM; RETINALDEHYDE; RETINOIDS; SPECTROMETRY, FLUORESCENCE;

EID: 77957340634     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.10-5852     Document Type: Article

References (75)

1. Delori FC, Dorey CK, Staurenghi G, Arend O, Goger DG, Weiter JJ. In vivo fluorescence of the ocular fundus exhibits retinal pigment epithelium lipofuscin characteristics. Invest Ophthalmol Vis Sci. 1995;36:718-729.
2. von Ruckmann A, Fitzke FW, Bird AC. Distribution of fundus autofluorescence with a scanning laser ophthalmoscope. Br J Ophthalmol. 1995;79:407-412.
3. von Ruckmann A, Fitzke FW, Bird AC. In vivo fundus autofluorescence in macular dystrophies. Arch Ophthalmol. 1997;115:609-615.
4. Holz FG, Bellman C, Staudt S, Schutt F, Volcker HE. Fundus autofluorescence and development of geographic atrophy in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2001;42: 1051-1056.
5. Robson AG, Mic haelides M, Saihan Z, et al. Functional characteristics of patients with retinal dystrophy that manifest abnormal parafoveal annuli of high density fundus autofluorescence: a review and update. Doc Ophthalmol. 2008;116:79-89.
6. Delori FC. Spectrophotometer for noninvasive measurement of intrinsic fluorescence and reflectance of the ocular fundus. Appl Opt. 1994;33:7439-7452.
7. Spaide RF. Autofluorescence imaging with the fundus camera. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin-Heidelberg: Springer- Verlag; 2007:49-54.
8. Morgan JI, Hunter JJ, Masella B, et al. Light-induced retinal changes observed with high-resolution autofluorescence imaging of the retinal pigment epithelium. Invest Ophthalmol Vis Sci. 2008;49: 3715-3729.
9. von Ruckmann A, Fitzke FW, Bird AC. Fundus autofluorescence in age-related macular disease imaged with a laser scanning ophthalmoscope. Invest Ophthalmol Vis Sci. 1997;38:478-486.
10. Delori FC, Goger DG, Dorey CK. Age-related accumulation and spatial distribution of lipofuscin in RPE of normal subjects. Invest Ophthalmol Vis Sci. 2001;42:1855-1866.
11. Delori FC, Keilhauer C, Sparrow JR, Staurenghi G. Origin of fundus autofluorescence. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin- Heidelberg: Springer-Verlag; 2007:17-29.
12. Del Priore LV, Kuo YH, Tezel TH. Age-related changes in human RPE cell density and apoptosis proportion in situ. Invest Ophthalmol Vis Sci. 2002;43:3312-3318.
13. Kim SR, Jang Y, Sparrow JR. Photooxidation of RPE lipofuscin bisretinoids enhanced fluorescence intensity. Vision Res. 2010;50: 729-736.
14. Sparrow JR. Lipofuscin of the retinal pigment epithelium. In: Holz FG, Schmitz-Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin-Heidelberg: Springer- Verlag; 2007:3-16.
15. Ng KP, Gugiu BG, Renganathan K, et al. Retinal pigment epithelium lipofuscin proteomics. Mol Cell Proteomics. 2008;7:1397- 1405.
16. Lorenz B, Wabbels B, Wegscheider E, Hamel CP, Drexler W, Presing MN. Lack of fundus autofluorescence to 488 nanometers from childhood on in patients with early-onset severe retinal dystrophy associated with mutations in RPE65. Ophthalmology. 2004; 111:1585-1594.
17. Parish CA, Hashimoto M, Nakanishi K, Dillon J, Sparrow JR. Isolation and one-step preparation of A2E and iso-A2E, fluorophores from human retinal pigment epithelium. Proc Natl Acad Sci U S A. 1998;95:14609-14613.
18. Fishkin N, Sparrow JR, Allikmets R, Nakanishi K. Isolation and characterization of a retinal pigment epithelial cell fluorophore: an all-trans-retinal dimer conjugate. Proc Natl Acad Sci U S A. 2005; 102:7091-7096.
19. Kim SR, Jang YP, Jockusch S, Fishkin NE, Turro NJ, Sparrow JR. The all-trans-retinal dimer series of lipofuscin pigments in retinal pigment epithelial cells in a recessive Stargardt disease model. Proc Natl Acad Sci U S A. 2007;104:19273-19278.
20. Wu Y, Fishkin NE, Pande A, Pande J, Sparrow JR. Novel lipofuscin bisretinoids prominent in human retina and in a model of recessive Stargardt disease. J Biol Chem. 2009;284:20155-20166.
21. Liu J, Itagaki Y, Ben-Shabat S, Nakanishi K, Sparrow JR. The biosynthesis of A2E, a fluorophore of aging retina, involves the formation of the precursor, A2-PE, in the photoreceptor outer segment membrane. J Biol Chem. 2000;275:29354-29360.
22. Ben-Shabat S, Parish CA, Vollmer HR, et al. Biosynthetic studies of A2E, a major fluorophore of RPE lipofuscin. J Biol Chem. 2002; 277:7183-7190.
23. Kim SR, He J, Yanase E, et al. Characterization of dihydro-A2PE: an intermediate in the A2E biosynthetic pathway. Biochemistry. 2007;46:10122-10129.
24. Bok D. Retinal photoreceptor-pigment epithelium interactions: The Friedenwald Lecture. Invest Ophthalmol Vis Sci. 1985;26: 1659-1694.
25. Mata NL, Weng J, Travis GH. Biosynthesis of a major lipofuscin fluorophore in mice and humans with ABCR-mediated retinal and macular degeneration. Proc Natl Acad Sci U S A. 2000;97:7154-7159.
26. Radu RA, Mata NL, Nusinowitz S, Liu X, Sieving PA, Travis GH. Treatment with isotretinoin inhibits lipofuscin and A2E accumulation in a mouse model of recessive Stargardt's macular degeneration. Proc Natl Acad Sci U S A. 2003;100:4742-4747.
27. Kim SR, Fishkin N, Kong J, Nakanishi K, Allikmets R, Sparrow JR. The Rpe65 Leu450Met variant is associated with reduced levels of the RPE lipofuscin fluorophores A2E and iso-A2E. Proc Natl Acad Sci U S A. 2004;101:11668-11672.
28. Radu RA, Han Y, Bui TV, et al. Reductions in serum vitamin A arrest accumulation of toxic retinal fluorophores: a potential therapy for treatment of lipofuscin-based retinal diseases. Invest Ophthalmol Vis Sci. 2005;46:4393-4401.
29. Maiti P, Kong J, Kim SR, Sparrow JR, Allikmets R, Rando RR. Small molecule RPE65 antagonists limit the visual cycle and prevent lipofuscin formation. Biochemistry. 2006;45:852-860.
30. Maeda A, Maeda T, Sun W, Zhang H, Baehr W, Palczewski K. Redundant and unique roles of retinol dehydrogenases in the mouse retina. Proc Natl Acad Sci U S A. 2007;104:19565-19570.
31. Molday LL, Rabin AR, Molday RS. ABCR expression in foveal cone photoreceptors and its role in Stargardt macular dystrophy. Nat Genet. 2000;25:257-258.
32. Papermaster DS, Schneider BG, Zorn MA, Kraehenbuhl JP. Immunocytochemical localization of a large intrinsic membrane protein to the incisures and margins of frog rod outer segment disks. J Cell Biol. 1978;78:415-425.
33. Sun H, Nathans J. Stargardt's ABCR is localized to the disc membrane of retinal rod outer segments. Nat Genet. 1997;17:15-16.
34. Sun H, Nathans J. ABCR, the ATP-binding cassette transporter responsible for Stargardt macular dystrophy, is an efficient target of all-trans retinal-mediated photo-oxidative damage in vitro: implications for retinal disease. J Biol Chem. 2001;276:11766-11774.
35. Allikmets R, Singh N, Sun H, et al. A photoreceptor cell-specific ATP-binding transporter gene (ABCR) is mutated in recessive Stargardt macular dystrophy. Nat Genet. 1997;15:236-246.
36. Shroyer NF, Lewis RA, Allikmets R, et al. The rod photoreceptor ATP-binding cassette transporter gene, ABCR, and retinal disease: from monogenic to multifactorial. Vision Res. 1999;39:2537-2544.
37. Eagle RC, Lucier AC, Bernardino VB, Yanoff M. Retinal pigment epithelial abnormalities in fundus flavimaculatus. Ophthalmology. 1980;87:1189-1200.
38. Weng J, Mata NL, Azarian SM, Tzekov RT, Birch DG, Travis GH. Insights into the function of Rim protein in photoreceptors and etiology of Stargardt's disease from the phenotype in abcr knockout mice. Cell. 1999;98:13-23.
39. Delori FC, Staurenghi G, Arend O, Dorey CK, Goger DG, Weiter JJ. In vivo measurement of lipofuscin in Stargardt's disease-Fundus flavimaculatus. Invest Ophthalmol Vis Sci. 1995;36:2327-2331.
40. Lois N, Holder GE, Bunce CV, Fitzke FW, Bird AC. Phenotypic subtypes of Stargardt macular dystrophy-fundus flavimaculatus. Arch Ophthalmol. 2001;119:359-369.
41. Chrispell JD, Feathers KL, Kane MA, et al. Rdh12 activity and effects on retinoid processing in the murine retina. J Biol Chem. 2009;284:21468-21477.
42. Schmitz-Valckenberg S, Jorzik J, Unnebrink K, Holz FG. Analysis of digital scanning laser ophthalmoscopy fundus autofluorescence images of geographic atrophy in advanced age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 2002;240:73-78.
43. Fleckenstein M, Issa PC, Helb HM, et al. High-resolution spectral domain-OCT imaging in geographic atrophy associated with agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2008; 49:4137-4144.
44. Sunness JS, Gonzalez-Baron J, Applegate CA, et al. Enlargement of atrophy and visual acuity loss in the geographic atrophy form of age-related macular degeneration. Ophthalmology. 1999;106: 1768-1779.
45. Holz FG, Bellmann C, Margaritidis M, Schutt F, Otto TP, Volcker HE. Patterns of increased in vivo fundus autofluorescence in the junctional zone of geographic atrophy of the retinal pigment epithelium associated with age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol. 1999;237:145-152.
46. Dreyhaupt J, Mansmann U, Pritsch M, Dolar-Szczasny J, Bindewald A, Holz FG. Modelling the natural history of geographic atrophy in patients with age-related macular degeneration. Ophthalmic Epidemiol. 2005;12:353-362.
47. Holz FG, Bindewald-Wittich A, Fleckenstein M, et al. Progression of geographic atrophy and impact of fundus autofluorescence patterns in age-related macular degeneration. Am J Ophthalmol. 2007;143:463-472.
48. Hwang JC, Chan JW, Chang S, Smith RT. Predictive value of fundus autofluorescence for development of geographic atrophy in agerelated macular degeneration. Invest Ophthalmol Vis Sci. 2006; 47:2655-2661.
49. Bindewald A, Bird AC, Dandekar SS, et al. Classification of fundus autofluorescence patterns in early age-related macular disease. Invest Ophthalmol Vis Sci. 2005;46:3309-3314.
50. Bindewald A, Schmitz-Valckenberg S, Jorzik JJ, et al. Classification of abnormal fundus autofluorescence patterns in the junctional zone of geographic atrophy in patients with age related macular degeneration. Br J Ophthalmol. 2005;89:874-878.
51. Scholl HPN, Bellmann C, Dandekar SS, Bird AC, Fitzke FW. Photopic and scotopic fine matrix mapping of retinal areas of increased fundus autofluorescence in patients with age-related maculopathy. Invest Ophthalmol Vis Sci. 2004;45:574-583.
52. Schmitz-Valckenberg S, Bultmann S, Dreyhaupt J, Bindewald A, Holz FG, Rohrschneider K. Fundus autofluorescence and fundus perimetry in the junctional zone of geographic atrophy in patients with age-related macular degeneration. Invest Ophthalmol Vis Sci. 2004;45:4470-4476.
53. Robson AG, Michaelides M, Luong VA, et al. Functional correlates of fundus autofluorescence abnormalities in patients with RPGR or RIMS1 mutations causing cone or cone rod dystrophy. Br J Ophthalmol. 2008;92:95-102.
54. Robson AG, Saihan Z, Jenkins SA, et al. Functional characterization and serial imaging of abnormal fundus autofluorescence in patients with retinitis pigmentosa and normal visual acuity. Br J Ophthalmol. 2006;90:472-479.
55. Popovic P, Jarc-Vidmar M, Hawlina M. Abnormal fundus autofluorescence in relation to retinal function in patients with retinitis pigmentosa. Graefes Arch Clin Exp Ophthalmol. 2005;243:1018-1027.
56. Michaelides M. Fundus autofluorescence in cone and cone-rod dystrophies. In: Lois N, Forrester JV, eds. Fundus Autofluorescence. Philadelphia: Lippincott Williams and Wilkins; 2009:153-166.
57. Gomes NL, Greenstein VC, Carlson JN, et al. A comparison of fundus autofluorescence and retinal structure in patients with Stargardt disease. Invest Ophthalmol Vis Sci. 2009;50:3953-3959.
58. Lois N, Halfyard A, Bird AC, Fitzke FW. Quantitative evaluation of fundus autofluorescence imaged 'in vivo' in eyes with retinal disease. Br J Ophthalmol. 2000;84:741-745.
59. Cideciyan AV, Aleman TS, Swider M, et al. Mutations in ABCA4 result in accumulation of lipofuscin before slowing of the retinoid cycle: a reappraisal of the human disease sequence. Hum Mol Genet. 2004;13:525-534.
60. Sparrow JR, Boulton M. RPE lipofuscin and its role in retinal photobiology. Exp Eye Res. 2005;80:595-606.
61. Holz FG, Fleckenstein M, Schmitz-Valckenberg S, Bird AC. Evaluation of fundus autofluorescence images. In: Holz FG, Schmitz- Valckenberg S, Spaide RF, Bird AC, eds. Atlas of Fundus Autofluorescence Imaging. Berlin-Heidelberg: Springer-Verlag; 2007:71-76.
62. Aleman TS, Soumittra N, Cideciyan AV, et al. CERKL mutations cause an autosomal recessive cone-rod dystrophy with inner retinopathy. Invest Ophthalmol Vis Sci. 2009 50:5944-5954.
63. Ben-Shabat S, Itagaki Y, Jockusch S, Sparrow JR, Turro NJ, Nakanishi K. Formation of a nona-oxirane from A2E, a lipofuscin fluorophore related to macular degeneration, and evidence of singlet oxygen involvement. Angew Chem Int Ed Engl. 2002;41:814-817.
64. Jang YP, Matsuda H, Itagaki Y, Nakanishi K, Sparrow JR. Characterization of peroxy-A2E and furan-A2E photooxidation products and detection in human and mouse retinal pigment epithelial cells lipofuscin. J Biol Chem. 2005;280:39732-39739.
65. Dowling JE, Sidman RL. Inherited retinal dystrophy in the rat. J Cell Biol. 1962;14:73-109.
66. Matthes MT, La Vail MM. Inherited retinal dystrophy in the RCS rat: composition of the outer segment debris zone. Prog Clin Biol Res. 1989;314:315-330.
67. D'Cruz PM, Yasumura D, Weir J, et al. Mutation of the receptor tyrosine kinase gene Mertk in the retinal dystrophic RCS rat. Hum Mol Genet. 2000;9:645-651.
68. Jolly C, Jeanny JC, Behar-Cohen F, Laugier P, Saied A. High-resolution ultrasonography of subretinal structure and assessment of retina degeneration in rat. Exp Eye Res. 2005;81:592-601.
69. LaVail MM, Battelle B-A. Influence of eye pigmentation and light deprivation on inherited retinal dystrophy in the rat. Exp Eye Res. 1975;21:167.
70. Hsu S, Molday RS. Glucose metabolism in photoreceptor outer segments. J Biol Chem. 1994;269:17954-17959.
71. Wolf-Schnurrbusch UEK, Enzmann V, Brinkmann CK, Wolf S. Morphological changes in patients with geographic atrophy assessed with a novel spectral OCT-SLO combination. Invest Ophthalmol Vis Sci. 2008;49:3095-3099.
72. Smith RT, Gomes NL, Barile G, Busuioc M, Lee N, Laine A. Lipofuscin and autofluorescence metrics in progressive STGD. Invest Ophthalmol Vis Sci. 2009;50:3907-3914.
73. Robson AG, Egan CA, Luong VA, Bird AC, Holder GE, Fitzke FW. Comparison of fundus autofluorescence in photopic and scotopic fine-matrix mapping in patients with retinitis pigmentosa and normal visual acuity. Invest Ophthalmol Vis Sci. 2004;45:4119-4125.
74. Keilhauer CN, Delori FC. Near-infrared autofluorescence imaging of the fundus: visualization of ocular melanin. Invest Ophthalmol Vis Sci. 2006;47:3556-3564.
75. Sarks JP, Sarks SH, Killingsworth MC. Evolution of geographic atrophy of the retinal pigment epithelium. Eye. 1988;2:552-577.